Investigational drugs for the treatment of dysmenorrhea
Review
OA: closed
CC0
AI-generated summary
This review details investigational drugs for dysmenorrhea, highlighting anti-inflammatories as promising but noting the need for more robust trials due to methodological limitations in current studies.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
INTRODUCTION: Dysmenorrhea is the most common cause of gynecological pain among women that has considerable impact on quality of life and psychosocial wellbeing. Non-steroidal anti-inflammatory drugs (NSAIDs) and hormonal therapies are most commonly used to treat dysmenorrhea. However, given these drugs are often associated with bothersome side effects and are less effective when there is an underlying cause contributing to dysmenorrhea (e.g. endometriosis), a patient-centered approach to managing dysmenorrhea is important. Various new drugs are currently being investigated for the treatment of primary and secondary dysmenorrhea.
AREAS COVERED: This review provides an updated overview on new therapeutic targets and investigational drugs for the treatment of primary and secondary dysmenorrhea. The authors describe the clinical development and implications of these drugs.
EXPERT OPINION: Among the investigative drugs discussed in this review, anti-inflammatories show the most promising results for the treatment of dysmenorrhea. However, given some trials have considerable methodological limitations, many drugs cannot be currently recommended. Research focused on understanding the mechanisms involved in menstruation and its associated symptoms will be important to identify new therapeutic targets for dysmenorrhea. Further robust clinical trials are required to better understand the efficacy and safety of investigational drugs for treating primary and secondary dysmenorrhea.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (100)
- Absence of Drug-Drug Interaction of Anastrozole on Levonorgestrel Delivered Simultaneously by an Intravaginal Ring: Results of a Phase 2 Trial via openalex
- “A day-to-day struggle”: A comparative qualitative study on experiences of women with endometriosis and chronic pelvic pain via openalex
- Cannabidiol for the Management of Endometriosis and Chronic Pelvic Pain via openalex
- Chronic Pelvic Pain in Women via openalex
- Combination GnRH antagonists for endometriosis: Balancing efficacy with side effects via openalex
- Combination therapy with telmisartan and parecoxib induces regression of endometriotic lesions via openalex
- Disease-modifying effects of natural Δ9-tetrahydrocannabinol in endometriosis-associated pain via openalex
- Dysmenorrhea in adolescents and young adults: an update on pharmacological treatments and management strategies via openalex
- Dysmenorrhea in adolescents and young adults: from pathophysiology to pharmacological treatments and management strategies via openalex
- Dysmenorrhea in adolescents: diagnosis and treatment via openalex
- Effect of palmitoylethanolamide-polydatin combination on chronic pelvic pain associated with endometriosis: preliminary observations via openalex
- Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study via openalex
- Efficacy and safety of ASP1707 for endometriosis-associated pelvic pain: the phase II randomized controlled TERRA study via openalex
- Efficacy and safety of oral gonadotropin-releasing hormone antagonists in moderate-to-severe endometriosis-associated pain: a systematic review and network meta-analysis via openalex
- Endogenous levels of prostaglandin F2alpha and its main metabolites in plasma and endometrium of normal and dysmenorrheic women via openalex
- Endometriosis via openalex
- Endometriosis via openalex
- Endometriosis and chronic pelvic pain have similar impact on women, but time to diagnosis is decreasing: an Australian survey via openalex
- Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review via openalex
- Endometriosis research priorities in Australia via openalex
- Gonadotropin-releasing hormone analogues for endometriosis via openalex
- Increased concentrations of eicosanoids and platelet-activating factor in menstrual blood from women with primary dysmenorrhea via openalex
- Investigational drugs for the treatment of endometriosis, an update on recent developments via openalex
- Leukotriene release by endometrium and myometrium throughout the menstrual cycle in dysmenorrhoea and menorrhagia via openalex
- Managing endometriosis: a cross-sectional survey of women in Australia via openalex
- Medical therapy options for endometriosis related pain, which is better? A systematic review and network meta-analysis of randomized controlled trials via openalex
- Nonhormonal therapy for endometriosis: a randomized, placebo-controlled, pilot study of cabergoline versus norethindrone acetate via openalex
- Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis via openalex
- Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2) via openalex
- Oral contraceptives for pain associated with endometriosis via openalex
- Pathogenesis and pathophysiology of endometriosis via openalex
- Pathophysiology, diagnosis, and management of endometriosis via openalex
- Pathophysiology of endometriosis-associated pain: A review of pelvic and central nervous system mechanisms via openalex
- Pelvic Pain: Diagnosis and Management via openalex
- Pelvic Pain: Diagnosis and Management via openalex
- Primary Dysmenorrhea: Assessment and Treatment via openalex
- Progestagens and anti-progestagens for pain associated with endometriosis via openalex
- Prostaglandin levels in menstrual fluid of nondysmenorrheic and of dysmenorrheic subjects with and without oral contraceptive or ibuprofen therapy via openalex
- Repurposing dichloroacetate for the treatment of women with endometriosis via openalex
- The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres via openalex
- The Clinical Significance of Endocannabinoids in Endometriosis Pain Management via openalex
- The molecular connections between the cannabinoid system and endometriosis via openalex
- The Place of Cannabinoids in the Treatment of Gynecological Pain via openalex
- The role of TGF-β in the pathophysiology of peritoneal endometriosis via openalex
- Transforming growth factor-β induced Warburg-like metabolic reprogramming may underpin the development of peritoneal endometriosis via openalex
- Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist via openalex
- Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist: Results from a Phase 2, Randomized Controlled Study via openalex
- Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone-antagonist: a randomized clinical trial via openalex
- Treatment recommendations for the management of persistent pelvic pain: a systematic review of international clinical practice guidelines via openalex
- Treatment use and satisfaction in Australian women with endometriosis: a mixed-methods study via openalex
- Treatment utilization for endometriosis symptoms: a cross-sectional survey study of lifetime experience via openalex
- Use of Cannabis for Self-Management of Chronic Pelvic Pain via openalex
- Use of combined hormonal contraceptives for the treatment of endometriosis-related pain: a systematic review of the evidence via openalex
- Use of dopamine agonists to target angiogenesis in women with endometriosis via openalex
- Uterine bleeding: how understanding endometrial physiology underpins menstrual health via openalex
- W3038225066 via openalex
- W3087746044 via openalex
- W3102612041 via openalex
- W3117130583 via openalex
- W3130420812 via openalex
- W3133755489 via openalex
- W3165294846 via openalex
- W3198025357 via openalex
- W3208489823 via openalex
- W4210757569 via openalex
- W4211075585 via openalex
- W4213040513 via openalex
- W4214754424 via openalex
- W4239039156 via openalex
- W4253935476 via openalex
- W4297880688 via openalex
- W4301603528 via openalex
- W4311364084 via openalex
- W4382895248 via openalex
- W4385427560 via openalex
- W6843108269 via openalex
- W1588200060 via openalex
- W1865743538 via openalex
- W1932581603 via openalex
- W1959597805 via openalex
- W1974514952 via openalex
- W1975765901 via openalex
- W1989400896 via openalex
- W1990024572 via openalex
- W1995939701 via openalex
- W1997134104 via openalex
- W2001142301 via openalex
- W2010495502 via openalex
- W2011253752 via openalex
- W2014774699 via openalex
- W2020492987 via openalex
- W2039090728 via openalex
- W2049019160 via openalex
- W2052871934 via openalex
- W2061625164 via openalex
- W2081880193 via openalex
- W2082084857 via openalex
- W2084350054 via openalex
- W2088162242 via openalex
- W2092854192 via openalex
Source provenance
- europepmc
- last seen: 2026-10-16T06:09:50.462052+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-10-16T06:08:01.012589+00:00
License: CC0
· commercial use OK